Shingrix vial kits
Ended Awarded
- Contract number
- SPE2DR26FQQ2R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,103
Award facts
- Contract value 100% obligated
- $1,102.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $1,102.87 delivery order to AmerisourceBergen Drug Corp for Shingrix vaccine vial kits, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price contract was issued on November 18, 2025, with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster (shingles) in immunocompetent adults and is widely used within the military and federal healthcare systems.
This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, generic and brand-name drugs, and related medical supplies. As a prime vendor to the Defense Health Agency and other federal healthcare systems, AmerisourceBergen maintains significant capacity to fulfill routine pharmaceutical procurements across multiple therapeutic domains supporting military medical readiness and troop health.
Quick answers
Who was awarded contract SPE2DR26FQQ2R?
SPE2DR26FQQ2R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FQQ2R worth?
The government has obligated $1,103 on SPE2DR26FQQ2R.
Is contract SPE2DR26FQQ2R an order under another contract?
Yes. SPE2DR26FQQ2R is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ2R competed?
The extent of competition for SPE2DR26FQQ2R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award